Cargando…
Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”
Autores principales: | Solerte, Sebastiano Bruno, D’Addio, Francesca, Fiorina, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669486/ https://www.ncbi.nlm.nih.gov/pubmed/33201344 http://dx.doi.org/10.1007/s00592-020-01630-5 |
Ejemplares similares
-
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
por: Solerte, Sebastiano Bruno, et al.
Publicado: (2020) -
Reply to the Letter to Editor Regarding “An Unusual Case of Critical Illness Polyneuromyopathy”
por: Mahashabde, Madhulika, et al.
Publicado: (2020) -
Reply to letter to editor
por: Sayanlar, Jennifer, et al.
Publicado: (2012) -
Reply to the letter to editor
por: Sahasrabudhe, Parag
Publicado: (2015) -
Reply to the Letter to the Editor
por: Garg, Megha
Publicado: (2021)